K-PIO-M Tablets

For The Use Of A Registered Medical Practitioner, A Hospital Or A Laboratory Only.

 

COMPOSITION
K-PIO-M Tablets
Each Uncoated Bilayered Tablet Contains:
Pioglitazone HCl IP eq. to Pioglitazone 15 mg
Metformin HCl IP (in sustained release form) 500 mg
INDICATIONS
K-PIO-M is indicated for DM in the following situations:

  • Moderate to severe type 2 DM as primary therapy.
  • In those type 2 DM patients wherein therapy with optimal doses of pioglitazone and metformin alone are providing suboptimal blood glucose control.
DOSAGE AND ADMINISTRATION
Oral: Adults: Usual recommended dose: 1 tablet once daily in the morning without regard to food, or as prescribed.
HOW SUPPLIED
10 Tablets per strip.